EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Looks Just Right With A 32% Price Jump
Despite an already strong run, EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) shares have been powering on, with a gain of 32% in the last thirty days. The last 30 days bring the annual gain to a very sharp 76%.
Since its price has surged higher, EyePoint Pharmaceuticals may be sending very bearish signals at the moment with a price-to-sales (or “P/S”) ratio of 18.6x, since almost half of all companies in the Pharmaceuticals industry in the United States have P/S ratios under 4.9x and even P/S lower than 1.7x are not unusual. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the highly elevated P/S.
Trump has pledged to “unleash” American oil and gas and these 15 US stocks have…
